GLP-1 agonists including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound were originally intended to treat type 2 diabetes and obesity
That broader metabolic action supports both weight loss and improved glucose metabolism , which can be especially helpful for people living with obesity and type 2 diabetes
The fiber in them can make you feel fuller to account for the increase in hunger you may experience. How to handle a gap in GLP-1 weight loss treatment Each manufacturer has specific recommendations about handling missed doses and longer
Una publicacin describa a una mujer posmenopusica de 71 aos que desarroll abruptamente anorgasmia tras comenzar con liraglutida, sin anomalas hormonales ni psicolgicas
Diabetes Care 38 , 476481 (2015)
Results vary depending on the treatment plan prescribed, individual adherence, medication selection, and each patient's health profile